Development, characterization and efficacy of niosomal diallyl disulfide in treatment of disseminated murine candidiasis
Tài liệu tham khảo
Anaissie, 1992, Opportunistic mycoses in the immunocompromised host: experience at cancer center and review, Clin Infect Dis, 14, 43, 10.1093/clinids/14.Supplement_1.S43
Pfaller, 1992, The impact of changing epidemiology of fungal infections in the 1990s, Eur J Clin Microbiol Infect Dis, 11, 287, 10.1007/BF01962067
Richardson, 1991, Opportunistic and pathogenic fungi, J Antimicrob Chemother, 28, 1, 10.1093/jac/28.suppl_A.1
Walsh, 1992, Invasive fungal infections: problems and challenges in developing new antifungal compound, 249
Prasad, 2005, Multidrug resistance in yeast Candida, Int Rev Cytol, 242, 215, 10.1016/S0074-7696(04)42005-1
Rex, 1995, Detection of amphotericin B-resistant Candida isolates in a broth-based system, Antimicrob Agents Chemother, 39, 906, 10.1128/AAC.39.4.906
Shah, 2005, The need for new therapeutic agents: what is in the pipeline?, Clin Microbiol Infect, 11, 36, 10.1111/j.1469-0691.2005.01141.x
Yin, 1999, Inhibitory effect of seven Allium plants upon three Aspergillus species, Int J Food Microbiol, 49, 49, 10.1016/S0168-1605(99)00061-6
Reuter, 1996, Therapeutic effects and applications of garlic and its preparations, 135
Cavallito, 1944, Allicin, the antibacterial principle of Allium sativum, I: isolation, physical properties, and antibacterial action, J Am Chem Soc, 66, 1950, 10.1021/ja01239a048
Cavallito, 1945, Allicin, the antibacterial principle of Allium sativum, III: its precursor and “essential oil” of garlic, J Am Chem Soc, 67, 1032, 10.1021/ja01222a501
Cavallito, 1944, Allicin, the antibacterial principle of Allium sativum, II: determination of the chemical structure, J Am Chem Soc, 66, 1952, 10.1021/ja01239a049
Lawson, 1998, Garlic: a review of its medicinal effects and indicated active compounds, 176
Thomson, 2003, Garlic [Allium sativum]: a review of its potential use as an anti-cancer agent, Curr Cancer Drug Targets, 3, 67, 10.2174/1568009033333736
Yoshida, 1999, An organosulphur compound isolated from oil-macerated garlic extract, and its antimicrobial effect, Biosci Biotechnol Biochem, 63, 588, 10.1271/bbb.63.588
Agarwal, 1996, Therapeutic actions of garlic constituents, Med Res Rev, 16, 111, 10.1002/(SICI)1098-1128(199601)16:1<111::AID-MED4>3.0.CO;2-5
Tsao, 2001, In vitro antimicrobial activity of four Diallyl sulfides occurring naturally in garlic and chinese leek oils, J Med Microbiol, 50, 646, 10.1099/0022-1317-50-7-646
Avato, 2000, Allyl sulfide constituents of garlic volatile oil as antimicrobial agents, Phytomedicine, 7, 239, 10.1016/S0944-7113(00)80010-0
Naganawa, 1996, Inhibition of microbial growth by ajoene, sulfur-containing compound derived from garlic, Appl Environ Microbiol, 62, 4238, 10.1128/aem.62.11.4238-4242.1996
Lemar, 2007, Diallyl disulfide depletes glutathione in Candida albicans: oxidative stress-mediated cell death studied by two-photon microscopy, Yeast, 24, 695, 10.1002/yea.1503
Perini, 1996, Niosomes as carriers for ophthalmic drugs: in vitro/in vivo evaluation, Boll Chim Farm, 135, 145
Uchegbu, 1995, Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse, Pharm Res, 12, 1019, 10.1023/A:1016210515134
Rogerson, 1988, The distribution of doxorubicin in mice following administration in niosomes, J Pharm Pharmacol, 40, 337, 10.1111/j.2042-7158.1988.tb05263.x
Chandraprakash, 1993, Effect of macrophage activation on plasma disposition of niosomal 3H-methotrexate in sarcoma-180 bearing mice, J Drug Target, 1, 143, 10.3109/10611869308996070
Luciani, 2004, Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes, Radiology, 231, 135, 10.1148/radiol.2311021559
Baillie, 1986, Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate, J Pharm Pharmacol, 38, 502, 10.1111/j.2042-7158.1986.tb04623.x
Baillie, 1985, The preparation and properties of niosomes non-ionic surfactant vesicles, J Pharm Pharmacol, 37, 863, 10.1111/j.2042-7158.1985.tb04990.x
Lawson, 1991, Identification and HPLC quantification of the sulpides and dialk(en)yl thiosulphinates in commercial garlic products, Planta Med, 57, 363, 10.1055/s-2006-960119
Nounou, 2006, In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels, Acta Pharm, 56, 311
Owais, 2000, Yeast vesicles as carriers for introducing macromolecules into cytoplasmic compartment of adherent cells, Eur J Biochem, 267, 3946, 10.1046/j.1432-1327.2000.01447.x
Khan, 2003, Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B, J Drug Target, 11, 93, 10.1080/1061186031000119093
National Committee for Clinical Laboratory Standards, 1995
Khan, 2004, Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice, FEMS Immunol Med Microbiol, 41, 249, 10.1016/j.femsim.2004.03.011
Lopez-Berestein, 1984, Altered tissue distribution of Amphotericin-B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans, Cancer Drug Deliv, 1, 199, 10.1089/cdd.1984.1.199
Ahmad, 1989, Liposomal Amphotericin-B in the control of experimental aspergillosis in mice: part I—relative therapeutic efficacy of free and liposomal Amphotericin-B, Indian J Biochem Biophys, 26, 351
Kabara, 1977, Antimicrobial lipids: natural and synthetic fatty acids and monoglycerides, Lipids, 12, 753, 10.1007/BF02570908
Bergsson, 2001, In vitro killing of Candida albicans by fatty acids and monoglycerides, Antimicrob Agents Chemother, 45, 3209, 10.1128/AAC.45.11.3209-3212.2001
Sahasrabudhe, 1969, Chromatographic analysis of sorbitan fatty acid esters, J Am Oil Chem Soc, 46, 8, 10.1007/BF02632701
Netea, 2010, Innate immune mechanisms for recognition and uptake of Candida species, Cell, 31, 346
Janeway, 2002, Innate immune recognition, Annu Rev Immunol, 20, 197, 10.1146/annurev.immunol.20.083001.084359
Alam, 2009, Efficacy of niosomal formulation of diallyl sulfide against experimental candidiasis in Swiss albino mice, Nanomedicine (Lond), 4, 713, 10.2217/nnm.09.60
Maroof, 2010, Potential use of liposomal diallyl sulfide in the treatment of experimental murine candidiasis, Biosci Rep, 30, 223, 10.1042/BSR20090068
Putman, 2000, Molecular properties of bacterial multidrug transporters, Microbiol Mol Biol Rev, 64, 672, 10.1128/MMBR.64.4.672-693.2000
Goren, 2000, Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump, Clin Cancer Res, 6, 1949